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Lipopolysaccharide (LPS) induces rapid necrosis of intradermal fibrosarcomas
in mice. The mechanism(s) by which LPS produces tumor necrosis has been
investigated using histocompatible LPS-sensitive (C3H/HeN) and LPS-resistant
(C3H/HeJ) mouse strains. C3H/HeN- or C3H/HeJ-derived fibrosarcomas were
necrotized by LPS when they were grafted onto C3H/HeN mice but were not
affected when growing on C3H/HeJ mice, indicating that LPS does not act
directly on the tumor itself. In contrast, lethally X-irradiated C3H/HeJ mice
exhibit necrosis of their tumors when reconstituted with C3H/HeN bone marrow
cells, whereas C3H/HeN mice no longer exert LPS-induced tumor necrosis after
the adoptive transfer of C3H/HeJ bone marrow cells. These findings clearly
indicate that LPS produces necrosis of tumors by activating host lymphoreticular
cells.
Lipopolysaccharide (LPS, endotoxin)-induced
tumor necrosis is awwell-known phenomenon (8,
13, 16), but the mechanisms) by which this
effect is mediated is not well understood. It has
been suggested that LPS acts directly on the
tumor cells (5) or that necrosis is due to vaso-
constriction and intravascular coaggulation
within the tumor (1). More recently it has been
reported that LPS induces the release ofa tumor
necrosis factor from macrophages in vivo (7, 10).
This finding as well as others suggests that LPS
exerts an influence on tumors by the production
of humoral mediators (6).
C3H/HeJ mice are resistant to all known ef-
fects of LPS, whereas the closely related, histo-
compatible C3H/HeN mouse strain is LPS sen-
sitive. In addition, it is possible to render C3H/
HeJ mice sensitive to LPS by the adoptive trans-
fer of C3H/HeN spleen or bone marrow cells
and render C3H/HeN mice LPS resistant by the
reciprocal transfer (9, 14). Using C3H/HeJ mice
and the adoptive transfer model system, we have
investigated the mechanism by which LPS in-
duces tumor necrosis. Our data suggest that LPS
does not act directly on the tumor cells or on
the host vasculature. Instead, our findings are
consistent with the hypothesis that LPS me-
diates tumor necrosis solely by an effect on
lymphoreticular cells.
Female mice, 6 to 12 weeks of age, were ob-
tained from the Division of Research Services,
National Institutes of Health (C3H/HeN) and
from the Jackson Laboratory, Bar Harbor,
Maine (C3H/HeJ). Escherichia coli K-235 LPS
was prepared by the phenol-water extraction
method of McIntire et al. (11). Bone marrow
cells were obtained by gently grinding and then
rinsing femurs and tibiae of the donor mice in
cold RPMI medium (GIBCO Laboratories,
Grand Island, N.Y.). Bone fragments were re-
moved by allowing them to settle for 5 min; the
cells were washed and then suspended in me-
dium to a concentration of 10i cells per ml. Cell
viability exceeded 90% as determined by the
exclusion of trypan blue dye. Mice received 850
R ofX-irradiation and were reconstituted within
6 h by tail vein injection of 107 bone marrow
cells. Four weeks after reconstitution, the mice
were used in the tumor experiments. In a study
to be reported separately, 850 R of X-irradiation
completely abrogated the ability of these mice
to form splenic colony-forming units (Michalek
et al., manuscript in preparation).
Tumors (fibrosarcomas) were induced by in-
jecting mice intradermally with 1 mg of 3-meth-
ylcholanthrene in 0.2 ml of trioctanoin (tricapry-
lin; Sigma Chemical Co., St. Louis, Mo.) on both
sides of the back. For tumor passage, solid pieces
were inoculated subcutaneously as previously
described (2). Experimental tumors were in-
duced by inoculating single tumor cell suspen-
sions which were obtained from minced tumor
fragments by enzymatic digestion (2). Tumor
cells (106) were injected intradermally, and after
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14 days the mice with tumors (7 ± 1 mm in
diameter) were injected intraperitoneally with
50 Mig of LPS. Tumor necrosis was determined
by visual inspection on days 1, 3, 5, and 7. The
results on day 3 are reported because the ne-
crotic response did not change later on. Only
tumors with >25% necrosis of the surface were
scored as positive. In certain experiments, an
established fibrosarcoma (tumor 1023) was used
that had been induced in a C3H/HeIcr male
mouse (12). All statistical analyses were per-
formed using the Fischer test (4).
To determine if the derivation of the tumor
from either endotoxin-sensitive or -resistant
mice would influence its sensitivity to LPS-in-
duced necrosis in vivo, tumors were induced
with methylcholanthrene in C3H/HeN and
C3H/HeJ mice and then tested in both C3H/
HeN and C3H/HeJ hosts for their LPS sensitiv-
ity. A C3H/HeN (LPS-sensitive)-derived tumor
was necrotized in >70% (11/15) of the animals
after injection of 50 ug of LPS when carried on
the endotoxin-sensitive C3H/HeN mouse strain;
only 7% (1/14) of the tumors were necrotized on
C3H/HeJ mice (P < 0.001; control tumor-bear-
ing mice of both strains, injected with saline,
showed no necrosis [0/5 for each strain]). In a
similar type of experiment employing a trans-
planted C3H/HeJ (LPS-resistant)-derived tu-
mor, again >60% (5/8) of the endotoxin-sensitive
mice (C3H/HeN) showed tumor necrosis
after injection of 50 ,ug of LPS, whereas none of
the tumors (0/7) on endotoxin-resistant (C3H/
HeJ) mice developed necrosis (P < 0.02; in sa-
line-injected controls, 0/5 of C3H/HeN and 1/4
of C3H/HeJ mice showed necrosis). To deter-
mine if the inability ofC3H/HeJ mice to necrose
transplanted tumors was due to an abnormal
tumor growth pattern in these mice, the growth
curves of a tumor derived from a LPS-sensitive
mouse were compared in C3H/HeN and C3H/
HeJ mice. The growth curves of the 1023 (C3H/
HeIcr) fibrosarcoma after intradermal injection
of C3H/HeJ and C3H/HeN mice with 106 cells
do not show any difference in growth rates of
this tumor in either group of mice (Fig. 1). These
experiments indicate that the origin ofthe tumor
does not influence its susceptibility to endotoxin-
induced necrosis and also suggest that LPS does
not act directly on the tumor itself.
Since the ability to necrotize tumors with LPS
is dependent upon the LPS sensitivity of the
host and not on the origin of the tumor, we
attempted to alter host sensitivity to LPS by X-
irradiation and reconstitution of the irradiated
recipient with bone marrow cells from either
LPS responder or nonresponder mice. The re-
sults obtained with these chimeric mice are
shown in Tables 1 and 2. The transfer of 107
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FIG. 1. Growth rate curves offibrosarcoma 1023 in
C3H/HeN and C3H/HeJ mice. A total of 106 tumor
cells in 0.05 ml ofRPMI 1640 were injected intrader-
mally on day 0 in the backs of the animals. Each
point represents themean tumor diameter ± standard
error determined from a group of 30 animals.
TABLE 1. Susceptibility of a C3H/HeN-derived
fibrosarcoma to LPS-induced necrosis when
implanted in C3H/HeN, C3H/HeJ, and chimeric
mice
Mice withSource of ncoi
bone marrow tumotc/ pRecipient' for reconstitu- tota "m
tin total miceinjected'
C3H/HeJ 2/14
C3H/HeJx C3H/HeJ 2/12 <0.001
C3H/HeJx C3H/HeN 15/16
C3H/HeN 11/15
C3H/HeNx C3H/HeN 18/19 <0.001
C3H/HeNx C3H/HeJ 5/29
a Subscript X denotes recipient animals that re-
ceived 850 R of X-irradiation before reconstitution
with 107 bone marrow cells.
b Necrotic response determined on day 3 after LPS
(50 jg) injection.
'Data combined from two separate experiments.
bone marrow cells from LPS responder mice
(C3H/HeN) to irradiated C3H/HeJ mice ren-
dered the latter (>90%) susceptible to the tu-
mor-necrotizing influence of LPS when en-
grafted with either the C3H/HeJ- or C3H/HeN-
derived fibrosarcoma. Reconstitution with au-
tologous bone marrow cells did not alter the
responsive state of the host. On the other hand,
C3H/HeN mice could be rendered almost totally
nonresponsive to tumor necrosis with LPS by
adoptive transfer of C3H/HeJ bone marrow
cells, since only 11 to 20% of these chimeras
exhibited LPS-induced tumor necrosis when en-
grafted with either type of tumor. Thus, adop-
tively transferred bone marrow cells caused sig-
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TABLE 2. Susceptibility of a C3H/HeJ-derived
fibrosarcoma to LPS-induced necrosis when
implanted in C3H/HeN, C3H/HeJ, and chimeric
mice
Mice withSource of ncoi
bone marrow tumorsicRecipients for reconstitu- tumors/ p
tin total micetion injected"
C3H/HeJ 0/15
C3H/HeJx C3H/HeJ 2/10 <0.004
C3H/HeJx C3H/HeN 6/6
C3H/HeN 10/11
C3H/HeNx C3H/HeN 3/4 <0.09
C3H/HeNx C3H/HeJ 2/10
a Subscript X denotes recipient animals that re-
ceived 850 R of X-irradiation before reconstitution
with 107 bone marrow cells.
b Injected with 50 ILg of LPS.
nificant changes in the in vivo response oftumor-
bearing mice to the necrotizing effect of endo-
toxin. These data demonstrate that the tumor
itself does not need to be LPS sensitive to be
necrosed, which is strong evidence against a
direct necrotic effect of LPS on the tumor. In
addition, since it is extremely unlikely that the
process of X-irradiation and bone marrow recon-
stitution would significantly alter the endothelial
cells of the host, our findings argue against a
direct effect of LPS on the tumor vasculature.
Finally, since there is no evidence for any defect
in LPS-induced complement activation in C3H/
HeJ mice, it is unlikely that LPS-induced tumor
necrosis is mediated via the complement system.
Therefore, the finding that adoptive transfer of
bone marrow cells transfers the ability of donor
cells to mediate tumor necrosis strongly suggests
that LPS acts on some bone marrow-derived cell
type to induce tumor necrosis. The precise cell(s)
and its mechanism of action remain unclear.
However, the data of Carswell et al. (7) indicate
that after BCG infection and endotoxin chal-
lenge macrophages release a soluble tumor ne-
crosis factor that exerts a cytotoxic effect on
tumor cells in vivo and in vitro. Macrophages
can also be activated by LPS to kill tumor cells
in vitro by a mechanism that requires cell-cell
contact (15). Thus, there exist at least two path-
ways by which LPS can initiate macrophage-
mediated tumor necrosis. In addition, it has
recently been reported that LPS-mediated tu-
mor graft rejection requires a radiosensitive
lymphoid cell (3). Therefore, it is not yet clear
whether other macrophage-related mechanisms
and/or lymphoid cells are involved. However,
our data strongly suggest that there is an essen-
tial requirement for lymphoreticular cells in the
initiation of LPS-induced tumor necrosis.
We have now demonstrated that C3H/HeJ
mice can be rendered sensitive to a number of
diverse LPS-induced events including lethality
(9) (Michalek et al., manuscript in preparation),
production of serum amyloid-associated protein
(14), interferon production (Michalek et al.,
manuscript in preparation), and tumor necrosis
by the adoptive transfer of LPS-sensitive bone
marrow cells. In addition, C3H/HeN mice can
also be rendered resistant to all these effects by
the adoptive transfer ofLPS-resistant bone mar-
row cells. Thus, there is ample evidence to sup-
port the notion that the diverse manifestations
of endotoxin reactions in the susceptible host
require the participation of endotoxin-sensitive
lymphoreticular cells and presumably a number
of soluble mediators derived from such cells.
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